Prostate Cancer - Results from #20460

Emerging therapeutic for the treatment of skeletal-related events associated with metastatic castrate-resistant prostate cancer - Abstract June 13, 2014

Evaluation of the clinical usefulness of a health-related Quality of Life Questionnaire in patients with prostate cancer - Abstract June 13, 2014

Prostate cancer antigen 3 test for prostate biopsy decision: A systematic review and meta analysis - Abstract June 13, 2014

American Cancer Society prostate cancer survivorship care guidelines - Abstract June 12, 2014

Traditional androgen ablation approaches to advanced prostate cancer: New insights - Abstract June 12, 2014

Utility of LHRH antagonists for advanced prostate cancer - Abstract June 12, 2014

Real-time elastography in the diagnosis of patients suspected of having prostate cancer: A meta-analysis - Abstract June 12, 2014

The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer - Abstract June 12, 2014

Beta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohort - Abstract June 11, 2014

User-centered design of quality of life reports for clinical care of patients with prostate cancer - Abstract June 11, 2014

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients - Abstract June 11, 2014

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy - Abstract June 11, 2014

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity - Abstract June 11, 2014

Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatment - Abstract June 11, 2014

The changing landscape of advanced and castration resistant prostate cancer: Latest science and revised definitions - Abstract June 11, 2014

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery - Abstract June 11, 2014

Readability of urologic pathology reports: The need for patient-centered approaches - Abstract June 11, 2014

Intermittent androgen deprivation therapy for prostate cancer: Translating randomized controlled trials into clinical practice - Abstract June 11, 2014

Defining young in the context of prostate cancer - Abstract June 11, 2014

Survival following primary androgen deprivation therapy for localized intermediate- or high-risk prostate cancer: Comparison with the life expectancy of the age-matched normal population - Abstract June 11, 2014

Page 1024 of 1439